Compare Bioavailability of RO7239361 After Subcutaneous Injection

Inclusion Criteria: * Healthy participant as determined by no significant deviations in normal medical and surgical history and assessments * Body Mass Index 18 kg/m2 to 32 kg/m2 * females must be of non-childbearing potential Exclusion Criteria: * tattoos or other skin findings on any of the potential injection sites * history of chronic muscle pain within 30 days prior to study treatment * prior history of IgG1 therapy Other protocol defined inclusion and exclusion criteria apply